[go: up one dir, main page]

CO5770113A1 - PEPTIDES TO DETECT OR INDUCE THE PRODUCTION OF ANTIBODIES ANTI THE HUMAN PAILOMA VIRUS, ANTI THE PROTEIN L1 OR ANTI PEPTIDES OF THIS PROTEIN - Google Patents

PEPTIDES TO DETECT OR INDUCE THE PRODUCTION OF ANTIBODIES ANTI THE HUMAN PAILOMA VIRUS, ANTI THE PROTEIN L1 OR ANTI PEPTIDES OF THIS PROTEIN

Info

Publication number
CO5770113A1
CO5770113A1 CO06040445A CO06040445A CO5770113A1 CO 5770113 A1 CO5770113 A1 CO 5770113A1 CO 06040445 A CO06040445 A CO 06040445A CO 06040445 A CO06040445 A CO 06040445A CO 5770113 A1 CO5770113 A1 CO 5770113A1
Authority
CO
Colombia
Prior art keywords
protein
peptides
virus
antibodies
derived
Prior art date
Application number
CO06040445A
Other languages
Spanish (es)
Inventor
Martinez Mauricio Urquiza
Murillo Manuel Elkin Patarroyo
Original Assignee
Fundacion Inst De Inmunologia De Colombia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacion Inst De Inmunologia De Colombia filed Critical Fundacion Inst De Inmunologia De Colombia
Priority to CO06040445A priority Critical patent/CO5770113A1/en
Priority to PCT/IB2007/001474 priority patent/WO2007129218A2/en
Publication of CO5770113A1 publication Critical patent/CO5770113A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

El péptido 1, derivado de la proteína L1, cuya secuencia aparece reportada en la siguiente Tabla o péptidos que contienen parte de la secuencia reportada en esta Tabla, que reaccionan con los anticuerpos inducidos por el VPH, la proteína L1 de este virus o péptidos derivados de esta proteína. <EMI FILE="06040445_1" ID="1" IMF=JPEG HE=50 WI=50 > El péptido 2, derivado de la proteína L1, cuya secuencia aparece reportada en la siguiente Tabla o péptidos que contienen parte de la secuencia reportada en esta Tabla, que reaccionan con los anticuerpos inducidos por el VPH, la proteína L1 de este virus o péptidos derivados de esta proteína. <EMI FILE="06040445_2" ID="2" IMF=JPEG HE=50 WI=50 > El péptido 3, derivado de la proteína L1, cuya secuencia aparece reportada en la siguiente Tabla, o péptidos que contienen parte de la secuencia reportada en la Tabla, que reaccionan con los anticuerpos inducidos por el VPH, la proteína L1 de este virus o péptidos derivados de esta proteína. <EMI FILE="06040445_3" ID="3" IMF=JPEG HE=50 WI=50 >Peptide 1, derived from the L1 protein, whose sequence is reported in the following Table or peptides that contain part of the sequence reported in this Table, that react with HPV-induced antibodies, the L1 protein of this virus or derived peptides of this protein <EMI FILE = "06040445_1" ID = "1" MFI = JPEG HE = 50 WI = 50> Peptide 2, derived from the L1 protein, whose sequence is reported in the following Table or peptides that contain part of the sequence reported in This Table, which react with the antibodies induced by HPV, the L1 protein of this virus or peptides derived from this protein. <EMI FILE = "06040445_2" ID = "2" MFI = JPEG HE = 50 WI = 50> Peptide 3, derived from the L1 protein, whose sequence is reported in the following Table, or peptides that contain part of the sequence reported in the Table, which react with the antibodies induced by HPV, the L1 protein of this virus or peptides derived from this protein. <EMI FILE = "06040445_3" ID = "3" MFI = JPEG HE = 50 WI = 50>

CO06040445A 2006-04-28 2006-04-28 PEPTIDES TO DETECT OR INDUCE THE PRODUCTION OF ANTIBODIES ANTI THE HUMAN PAILOMA VIRUS, ANTI THE PROTEIN L1 OR ANTI PEPTIDES OF THIS PROTEIN CO5770113A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CO06040445A CO5770113A1 (en) 2006-04-28 2006-04-28 PEPTIDES TO DETECT OR INDUCE THE PRODUCTION OF ANTIBODIES ANTI THE HUMAN PAILOMA VIRUS, ANTI THE PROTEIN L1 OR ANTI PEPTIDES OF THIS PROTEIN
PCT/IB2007/001474 WO2007129218A2 (en) 2006-04-28 2007-04-27 Tpeptides for detecting or inducing production of antibodies against human papilloma virus, l1 protein or peptides from this protein.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO06040445A CO5770113A1 (en) 2006-04-28 2006-04-28 PEPTIDES TO DETECT OR INDUCE THE PRODUCTION OF ANTIBODIES ANTI THE HUMAN PAILOMA VIRUS, ANTI THE PROTEIN L1 OR ANTI PEPTIDES OF THIS PROTEIN

Publications (1)

Publication Number Publication Date
CO5770113A1 true CO5770113A1 (en) 2007-06-29

Family

ID=38668145

Family Applications (1)

Application Number Title Priority Date Filing Date
CO06040445A CO5770113A1 (en) 2006-04-28 2006-04-28 PEPTIDES TO DETECT OR INDUCE THE PRODUCTION OF ANTIBODIES ANTI THE HUMAN PAILOMA VIRUS, ANTI THE PROTEIN L1 OR ANTI PEPTIDES OF THIS PROTEIN

Country Status (2)

Country Link
CO (1) CO5770113A1 (en)
WO (1) WO2007129218A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018290856A1 (en) * 2017-06-28 2020-01-02 Regeneron Pharmaceuticals, Inc. Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
CN113512109B (en) * 2021-03-09 2022-03-25 北京康乐卫士生物技术股份有限公司 Monoclonal neutralizing antibody against human papillomavirus 31 and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8803870D0 (en) * 1988-10-28 1988-10-28 Medscand Ab METHOD FOR DETECTION OF HUMAN PAPILLOMAVIRUS (HPV) FOR DIAGNOSTIC PURPOSES

Also Published As

Publication number Publication date
WO2007129218A2 (en) 2007-11-15
WO2007129218A3 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
ES2525477T3 (en) Humanized anti-factor D antibodies
NO20063026L (en) antibodies
RU2015147300A (en) HUMANIZED ANTIBODIES TO CXCR5, THEIR DERIVATIVES AND THEIR APPLICATION
RS54046B1 (en) Anti-myostatin antibodies
EA201491049A1 (en) ANTI-TRACT FUSE PROTEIN
ES2676023T3 (en) IL-22 polypeptides and IL-22 Fc fusion proteins and methods of use
ES2668967T3 (en) Escherichia coli immunogens with enhanced solubility
EA201400568A1 (en) ALBUMINS CONNECTING ANTIBODIES AND THEIR CONNECTING FRAGMENTS
RS53851B1 (en) Anticancer fusion protein
SG10201407640PA (en) Hepatitis b virus specific antibody and uses thereof
EA201390820A1 (en) Fusion protein against cancer
RS52439B (en) Human antibodies to human delta like ligand 4
FI3677591T3 (en) Anti-cd38 antibodies and fusions to attenuated interferon alpha-2b
AR094149A1 (en) MULTIFUNCTION PROTEINS THAT INCLUDE MULTIVALLY UNITED CLASS I CHM BY DISULFURE
CL2008003784A1 (en) Humanized anti-hepatitis c virus e2 protein antibody or binding fragment; nucleic acid that encodes it; vector and host cell comprising said nucleic acid; method of producing the antibody; pharmaceutical composition comprising the antibody
NZ596295A (en) Anti-5T4 antibodies and uses thereof
NZ595736A (en) Chimeric viruses presenting non-native surface proteins and uses thereof
ES2421719T3 (en) Deamidated recombinant gliadin antigen
MX2014003689A (en) Antibodies against tl1a and uses thereof.
AR093641A1 (en) ELIMINATION OF CANCER CELLS BY SPECIFIC CIRCULATING T VIRUS CELLS USING MULTIFUNCTION PROTEINS THAT INCLUDE CLH CLASS I WITH DIANA IN CANCER CELLS
ECSP10010327A (en) PEPTIDES OF FVIII AND ITS USE FOR TOLERANT HEMOPHYLICS
EP4481045A3 (en) Dna-binding protein using ppr motif, and use thereof
WO2009038026A1 (en) Ctl inducer composition
CL2007002389A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the treatment and / or prophylaxis of obesity, hirsutism, hypertrichosis and viric warts.
CO5770113A1 (en) PEPTIDES TO DETECT OR INDUCE THE PRODUCTION OF ANTIBODIES ANTI THE HUMAN PAILOMA VIRUS, ANTI THE PROTEIN L1 OR ANTI PEPTIDES OF THIS PROTEIN

Legal Events

Date Code Title Description
FC Application refused